Page last updated: 2024-08-23

bezafibrate and Atherogenesis

bezafibrate has been researched along with Atherogenesis in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (50.00)	29.6817
2010's	4 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Glukhov, AI; Javadov, S; Khuchua, Z; Strauss, AW	1
Imamura, H; Kawana, H; Nagayama, D; Nakamura, S; Ohira, M; Oka, R; Saiki, A; Sato, Y; Shimizu, N; Shirai, K; Tanaka, S; Tatsuno, I; Watanabe, Y; Yamaguchi, T	1
Fujita, N; Furukawa, Y; Inaba, T; Ishibashi, S; Itabashi, N; Nagashima, S; Okada, K; Okazaki, M; Tazoe, F; Yagyu, H	1
Al-Hiari, Y; Al-Qirim, T; El-Huneidi, W; Shahwan, M; Shattat, G; Sweidan, K	1
DU, J; Hao, G; Liu, JH; Lü, Y; Wang, GZ; Zeng, XJ; Zhang, LK; Zhang, YC; Zhao, DH	1
Duriez, P; Fruchart, JC	1
Chinetti, G; Fontaine, C; Fruchart, JC; Robillard, R; Staels, B	1
Ayaori, M; Fayad, ZA; Kihara, T; Kusuhara, M; Momiyama, Y; Nagata, M; Nakamura, H; Nakaya, K; Ogura, M; Ohmori, R; Ohsuzu, F; Sawada, S; Tanaka, N; Taniguchi, H; Yonemura, A	1

Reviews

3 review(s) available for bezafibrate and Atherogenesis

Article	Year
Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases. International journal of molecular sciences, 2018, Nov-04, Volume: 19, Issue:11 Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Bezafibrate; Cardiomyopathies; Cardiotonic Agents; Energy Metabolism; Fatty Acids; Gene Expression Regulation; Heart Failure; Humans; Hypolipidemic Agents; Lipid Metabolism; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptors; Signal Transduction	2018
Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism. Drugs of today (Barcelona, Spain : 1998), 2006, Volume: 42, Issue:1 Topics: Animals; Anticholesteremic Agents; Atherosclerosis; Bezafibrate; Biological Transport; Cholesterol, HDL; Clofibric Acid; Coronary Artery Disease; Fenofibrate; Gemfibrozil; Humans; Hypercholesterolemia; Hypertriglyceridemia; Hypolipidemic Agents; Liver; PPAR alpha; Randomized Controlled Trials as Topic; Triglycerides	2006
Fibrates. Handbook of experimental pharmacology, 2005, Issue:170 Topics: Animals; Atherosclerosis; Bezafibrate; Cholesterol; Clofibrate; Endothelium, Vascular; Fenofibrate; Humans; Hypolipidemic Agents; Lipid Metabolism; PPAR alpha	2005

Trials

2 trial(s) available for bezafibrate and Atherogenesis

Article	Year
Bezafibrate Ameliorates Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Hypertriglyceridemic Patients with Type 2 Diabetes Mellitus. Journal of atherosclerosis and thrombosis, 2019, Jul-01, Volume: 26, Issue:7 Topics: Aged; Ankle; Ankle Brachial Index; Atherosclerosis; Bezafibrate; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Oxidative Stress; Risk Factors; Triglycerides; Vascular Stiffness	2019
Effect of bezafibrate therapy on atherosclerotic aortic plaques detected by MRI in dyslipidemic patients with hypertriglyceridemia. Atherosclerosis, 2008, Volume: 196, Issue:1 Topics: Aged; Aorta; Atherosclerosis; Bezafibrate; Diffusion Magnetic Resonance Imaging; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Magnetic Resonance Angiography; Male; Middle Aged; Prospective Studies	2008

Article

Year

Bezafibrate Ameliorates Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Hypertriglyceridemic Patients with Type 2 Diabetes Mellitus.

Journal of atherosclerosis and thrombosis, 2019, Jul-01, Volume: 26, Issue:7

Topics: Aged; Ankle; Ankle Brachial Index; Atherosclerosis; Bezafibrate; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Oxidative Stress; Risk Factors; Triglycerides; Vascular Stiffness

2019

Effect of bezafibrate therapy on atherosclerotic aortic plaques detected by MRI in dyslipidemic patients with hypertriglyceridemia.

Atherosclerosis, 2008, Volume: 196, Issue:1

Topics: Aged; Aorta; Atherosclerosis; Bezafibrate; Diffusion Magnetic Resonance Imaging; Female; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Magnetic Resonance Angiography; Male; Middle Aged; Prospective Studies

2008

Other Studies

3 other study(ies) available for bezafibrate and Atherogenesis

Article	Year
Cholesterol reduction and atherosclerosis inhibition by bezafibrate in low-density lipoprotein receptor knockout mice. Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:5 Topics: Animals; Aorta; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Bezafibrate; Blood Glucose; Chemokine CCL2; Cholesterol, HDL; Disease Models, Animal; Hypolipidemic Agents; Lipids; Lipoprotein Lipase; Lipoproteins; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, LDL; RNA, Messenger; Triglycerides	2008
The hypolipidemic activity of novel benzofuran-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats: a comparison with bezafibrate. Journal of enzyme inhibition and medicinal chemistry, 2010, Volume: 25, Issue:6 Topics: Animals; Anthracenes; Atherosclerosis; Benzofurans; Bezafibrate; Cholesterol; Cholesterol, HDL; Detergents; Drug Design; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Molecular Structure; Polyethylene Glycols; Random Allocation; Rats; Rats, Wistar; Time Factors; Triglycerides	2010
[Oxidized low density lipoprotein and peroxisome proliferator-activated receptor α induced endogenous fibroblast growth factor 21 upregulation is protective against apoptosis in cardiac endothelial cells]. Zhonghua xin xue guan bing za zhi, 2010, Volume: 38, Issue:12 Topics: Animals; Apoptosis; Atherosclerosis; Bezafibrate; Cells, Cultured; Endothelium, Vascular; Fibroblast Growth Factors; Lipoproteins, LDL; PPAR alpha; Rats; Rats, Wistar	2010